Dexamethasone/Povidone Eye Drops versus Artificial Tears for Treatment of Presumed Viral Conjunctivitis: A Randomized Clinical Trial

REFERENCES

• Sambursky RP, Fram N, Cohen EJ. The prevalence of adenoviral conjunctivitis at the Wills Eye Hospital Emergency Room. Optometry 2007;78:236–239
   PubMedGoogle Scholar
• Cooper RJ, Hallett R, Tullo AB, Klapper PE. The epidemiology of adenovirus infections in Greater Manchester, UK 1982-96. Epidemiol Infect 2000;125:333–345
   PubMed Web of Science ®Google Scholar
• Hussain MA, Costello P, Morris DJ, Bailey AS, Corbitt G, Cooper RJ, et al. Comparison of primer sets for detection of fecal and ocular adenovirus infection using the polymerase chain reaction. J Med Virol 1996;49:187–194
   PubMed Web of Science ®Google Scholar
• Scott IU. Viral conjunctivitis. 2014 Jun 5. Available from: http://emedicine.medscape.com/article/1191370-overview [last accessed 13 Jun 2014]
   Google Scholar
• Park S-W, Lee C-S, Jang H-C, Kim E-C, Oh M, Choe K-W. Rapid identification of the coxsackievirus A24 variant by molecular serotyping in an outbreak of acute hemorrhagic conjunctivitis. J Clin Microbiol 2005;43:1069–1071
   PubMed Web of Science ®Google Scholar
• Kimura R, Migita H, Kadonosono K, Uchio E. Is it possible to detect the presence of adenovirus in conjunctiva before the onset of conjunctivitis? Acta Ophthalmol 2009;87:44–47
   PubMed Web of Science ®Google Scholar
• Udeh BL, Schneider JE, Ohsfeldt RL. Cost effectiveness of a point-of-care test for adenoviral conjunctivitis. Am J Med Sci 2008;336:254–264
   PubMed Web of Science ®Google Scholar
• Kaneko H, Maruko I, Iida T, Ohguchi T, Aoki K, Ohno S, Suzutani T. The possibility of human adenovirus detection from the conjunctiva in asymptomatic cases during nosocomial infection. Cornea 2008;27:527–530
   PubMed Web of Science ®Google Scholar
• Sambursky R, Trattler W, Tauber S, Starr C, Friedberg M, Boland T, et al. Sensitivity and specificity of the AdenoPlus test for diagnosing adenoviral conjunctivitis. JAMA Ophthalmol 2013;131:17–22
   PubMed Web of Science ®Google Scholar
• Romanowski EG, Roba LA, Wiley L, Araullo-Cruz T, Gordon YJ. The effects of corticosteroids of adenoviral replication. Arch Ophthalmol 1996;114:581–585
   PubMed Web of Science ®Google Scholar
• Romanowski EG, Yates KA, Gordon YJ. Antiviral prophylaxis with twice daily topical cidofovir protects against challenge in the adenovirus type 5/New Zealand rabbit ocular model. Antiviral Res 2001;52:275–280
   PubMed Web of Science ®Google Scholar
• Hillenkamp J, Reinhard T, Ross RS, Böhringer D, Cartsburg O, Roggendorf M, et al. The effects of cidofovir 1% with and without cyclosporin a 1% as a topical treatment of acute adenoviral keratoconjunctivitis: a controlled clinical pilot study. Ophthalmology 2002;109:845–850
   PubMed Web of Science ®Google Scholar
• Meyer-Rüsenberg B, Loderstädt U, Richard G, Kaulfers P-M, Gesser C. Epidemic keratoconjunctivitis: the current situation and recommendations for prevention and treatment. Dtsch Arztebl Int 2011;108:475–480
   PubMed Web of Science ®Google Scholar
• Awan MA, Agarwal PK, Watson DG, McGhee CNJ, Dutton GN. Penetration of topical and subconjunctival corticosteroids into human aqueous humour and its therapeutic significance. Br J Ophthalmol 2009;93:708–713
   PubMed Web of Science ®Google Scholar
• Weijtens O, Schoemaker RC, Romijn FPHTM, Cohen AF, Lentjes EGWM, van Meurs JC. Intraocular penetration and systemic absorption after topical application of dexamethasone disodium phosphate. Ophthalmology 2002;109:1887–1891
   PubMed Web of Science ®Google Scholar
• Pelletier JS, Stewart K, Trattler W, Ritterband DC, Braverman S, Samson CM, et al. A combination povidone-iodine 0.4%/dexamethasone 0.1% ophthalmic suspension in the treatment of adenoviral conjunctivitis. Adv Ther 2009;26:776–783
   PubMed Web of Science ®Google Scholar
• Holland EJ, Bartlett JD, Paterno MR, Usner DW, Comstock TL. Effects of loteprednol/tobramycin versus dexamethasone/tobramycin on intraocular pressure in healthy volunteers. Cornea 2008;27:50–55
   PubMed Web of Science ®Google Scholar
• Mohan N, Gupta V, Tandon R, Gupta SK, Vajpayee RB. Topical ciprofloxacin-dexamethasone combination therapy after cataract surgery: randomized controlled clinical trial. J Cataract Refract Surg 2001;27:1975–1978
   PubMed Web of Science ®Google Scholar
• Kadam SP. Application of betadine (povidone iodine) to infected corneal ulcer. Indian J Ophthalmol 1987;35:135–136
   PubMedGoogle Scholar
• Isenberg SJ, Apt L, Valenton M, Del Signore M, Cubillan L, Labrador MA, et al. A controlled trial of povidone-iodine to treat infectious conjunctivitis in children. Am J Ophthalmol 2002;134:681–688
   PubMed Web of Science ®Google Scholar
• Isenberg SJ. The ocular application of povidone-iodine. Community Eye Health 2003;16:30–31
   PubMedGoogle Scholar
• Safar A, Dellimore MC. The effect of povidone iodine flush versus drops on conjunctival colonization before intravitreal injections. Int Ophthalmol 2007;27:307–312
   PubMedGoogle Scholar
• Ferguson AW, Scott JA, McGavigan J, Elton RA, McLean J, Schmidt U, et al. Comparison of 5% povidone-iodine solution against 1% povidone-iodine solution in preoperative cataract surgery antisepsis: a prospective randomised double blind study. Br J Ophthalmol 2003;87:163–167
   PubMed Web of Science ®Google Scholar
• Benevento WJ, Murray P, Reed CA, Pepose JS. The sensitivity of Neisseria gonorrhoeae, Chlamydia trachomatis, and herpes simplex type II to disinfection with povidone-iodine. Am J Ophthalmol 1990;109:329–333
   PubMed Web of Science ®Google Scholar
• Melki SA, Safar A, Yaghouti F, Scharper P, Scharper M, Zeligs B, et al. Effect of topical povidone-iodine versus topical ofloxacin on experimental Staphylococcus keratitis. Graefes Arch Clin Exp Ophthalmol 2000;238:459–462
   PubMed Web of Science ®Google Scholar
• Berkelman RL, Holland BW, Anderson RL. Increased bactericidal activity of dilute preparations of povidone-iodine solutions. J Clin Microbiol 1982;15:635–639
   PubMed Web of Science ®Google Scholar
• Monnerat N, Bossart W, Thiel MA. [Povidone-iodine for treatment of adenoviral conjunctivitis: an in vitro study]. Klin Monbl Augenheilkd 2006;223:349–352
   PubMed Web of Science ®Google Scholar
• Kawana R, Kitamura T, Nakagomi O, Matsumoto I, Arita M, Yoshihara N, et al. Inactivation of human viruses by povidone-iodine in comparison with other antiseptics. Dermatology (Basel) 1997;195:29–35
   PubMed Web of Science ®Google Scholar
• Clement C, Capriotti JA, Kumar M, Hobden JA, Foster TP, Bhattacharjee PS, et al. Clinical and antiviral efficacy of an ophthalmic formulation of dexamethasone povidone-iodine in a rabbit model of adenoviral keratoconjunctivitis. Invest Ophthalmol Vis Sci 2011;52:339–344
   PubMed Web of Science ®Google Scholar
• Kinloch R, Mackay N, Mautner V. Adenovirus hexon. Sequence comparison of subgroup C serotypes 2 and 5. J Biol Chem 1984;259:6431–6436
   PubMed Web of Science ®Google Scholar
• Turner PC, Bailey AS, Cooper RJ, Morris DJ. The polymerase chain reaction for detecting adenovirus DNA in formalin-fixed, paraffin-embedded tissue obtained post mortem. J Infect 1993;27:43–46
   PubMed Web of Science ®Google Scholar
• Allard A, Girones R, Juto P, Wadell G. Polymerase chain reaction for detection of adenoviruses in stool samples. J Clin Microbiol 1991;29:2683
   PubMed Web of Science ®Google Scholar
• Morris DJ, Bailey AS, Cooper RJ, Turner PC, Jackson R, Corbitt G, Tullo AB. Polymerase chain reaction for rapid detection of ocular adenovirus infection. J Med Virol 1995;46:126–132
   PubMed Web of Science ®Google Scholar
• Shiuey Y, Ambati BK, Adamis AP. A randomized, double-masked trial of topical ketorolac versus artificial tears for treatment of viral conjunctivitis. Ophthalmology 2000;107:1512–1517
   PubMed Web of Science ®Google Scholar
• Ward JB, Siojo LG, Waller SG. A prospective, masked clinical trial of trifluridine, dexamethasone, and artificial tears in the treatment of epidemic keratoconjunctivitis. Cornea 1993;12:216–221
   PubMed Web of Science ®Google Scholar
• Baudouin C, de Lunardo C. Short-term comparative study of topical 2% carteolol with and without benzalkonium chloride in healthy volunteers. Br J Ophthalmol 1998;82:39–42
   PubMed Web of Science ®Google Scholar
• Ishibashi T, Yokoi N, Kinoshita S. Comparison of the short-term effects on the human corneal surface of topical timolol maleate with and without benzalkonium chloride. J Glaucoma 2003;12:486–490
   PubMed Web of Science ®Google Scholar
• Levrat F, Pisella PJ, Baudouin C. [Clinical tolerance of antiglaucoma eyedrops with and without a preservative. Results of an unpublished survey in Europe]. J Fr Ophtalmol 1999;22:186–191
   PubMed Web of Science ®Google Scholar
• Chou S-F, Lin C-H, Chang S-W. Povidone-iodine application induces corneal cell death through fixation. Br J Ophthalmol 2011;95:277–283
   PubMed Web of Science ®Google Scholar
• Bélec L, Tevi-Benissan C, Bianchi A, Cotigny S, Beumont-Mauviel M, Si-Mohamed A, et al. In vitro inactivation of Chlamydia trachomatis and of a panel of DNA (HSV-2, CMV, adenovirus, BK virus) and RNA (RSV, enterovirus) viruses by the spermicide benzalkonium chloride. J Antimicrob Chemother 2000;46:685–693
   PubMed Web of Science ®Google Scholar
• Lazzaro DR, Abulawi K, Hajee ME. In vitro cytotoxic effects of benzalkonium chloride on adenovirus. Eye Contact Lens 2009;35:329–332
   PubMed Web of Science ®Google Scholar
• Wilkins MR, Khan S, Bunce C, Khawaja A, Siriwardena D, Larkin DFP. A randomised placebo-controlled trial of topical steroid in presumed viral conjunctivitis. Br J Ophthalmol. 2011;95:1299–1303
   PubMed Web of Science ®Google Scholar
• Trauzettel-Klosinski S, Sundmacher R, Wigand R. [The effects of topical steroids in epidemic kerato-conjunctivitis (author’s transl)]. Klin Monbl Augenheilkd 1980;176:899–906
   PubMed Web of Science ®Google Scholar